The extreme warrant coverage (over 5:1 ratio of warrant shares to registered shares) signals aggressive capital raising at a deep discount, which will likely pressure the stock. Monitor for stockholder approval of the Series A-1/A-2 warrants — if approved, the overhang could cap any upside for months. The CEO and director participation provides some signal of confidence, but the sheer dilution magnitude outweighs this. Consider short-term bearish bias until the registration statement for warrant resale becomes effective and the overhang clears.
Price Chart
Executive Summary
Amesite Inc. is raising approximately $1.0 million in gross proceeds through a registered direct offering of 696,866 shares of common stock at $1.435 per share, alongside a concurrent private placement of pre-funded warrants and Series A-1/A-2 warrants with significant potential dilution. The offering price represents a ~9% discount to the last sale price of $1.58 on April 24, 2026, and the company expects net proceeds of ~$845,000 for general corporate and working capital purposes. The massive warrant coverage (up to ~3.6 million additional shares exercisable at $1.435) creates substantial overhang and future dilution risk for existing shareholders.
Key Facts
- Offering 696,866 shares of common stock at $1.435 per share, a ~9% discount to the $1.58 closing price on April 24, 2026
- Gross proceeds of approximately $1,000,002.71; net proceeds of ~$845,002 after fees and expenses
- Concurrent private placement includes Pre-Funded Warrants for 696,866 shares at $0.001, Series A-1 Warrants for 1,811,850 shares at $1.435, and Series A-2 Warrants for 1,811,850 shares at $1.435
- Total potential dilution from warrants and pre-funded warrants: up to ~4.3 million additional shares if fully exercised
- CEO Ann Marie Sastry and director George Parmer are investing $250,000 and $350,000 respectively in the private placement on same terms as other investors
- Net tangible book value as of December 31, 2025 was $969,000 ($0.21 per share); after offering, adjusted to ~$1.82 million ($0.35 per share)
- New investors face immediate dilution of $1.09 per share from offering price to adjusted book value
- Placement agent H.C. Wainwright receives 7.0% cash fee plus warrants for 7.0% of shares sold
Financial Impact
~$1.0 million gross proceeds raised, but with massive warrant overhang potentially diluting existing shareholders by up to 94% if all warrants exercised
Risk Factors
- Massive dilution from up to ~4.3 million additional shares if all warrants exercised, nearly doubling the current 4.57 million share count
- Stock price may trade down toward the $1.435 warrant exercise price, creating a ceiling
- Nasdaq continued listing risk given micro-cap status and potential for further capital needs
- Forward-looking statements about AI healthcare pivot are unproven; no revenue or earnings data provided in this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001213900-26-048323 |
| Document: 0001213900-26-048323-index-headers.html | 0001213900-26-048323 |
| Document: 0001213900-26-048323-index.html | 0001213900-26-048323 |
| Document: 0001213900-26-048323.txt | 0001213900-26-048323 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | DEFA14A | $0.8825 | awaiting T+60 | — | $0.5630 (−36.20%) |
Oct 14, 2026 13d ago | DEF 14A | $0.8825 | awaiting T+60 | — | $0.5630 (−36.20%) |
Jun 3, 2026 20w ago | DEFA14A | $1.39 $1.06 | ▼ −23.74% | ▼ −25.62% | $0.5630 (−59.50%) |
May 29, 2026 21w ago | EFFECT | $1.41 $1.16 | ▲ +17.73% | ▲ +18.91% | $0.5630 (+60.07%) |
May 19, 2026 23w ago | 8-K | $1.73 $1.07 | ▼ −38.15% | ▼ −44.44% | $0.5630 (−67.46%) |
May 12, 2026 24w ago | S-1 | $0.8310 $1.05 | ▼ −26.35% | ▼ −21.92% | $0.5630 (+32.25%) |
Apr 28, 2026 26w ago | 424B5 | $0.9800 $0.9519 | ▲ +2.87% | ▲ +6.86% | $0.5630 (+42.55%) |
Apr 27, 2026 26w ago | Press Release | $1.05 $0.9802 | ▲ +6.65% | ▲ +11.42% | $0.5630 (+46.38%) |
Apr 27, 2026 26w ago | Press Release | $1.05 $0.9802 | ▼ −6.65% | ▼ −11.42% | $0.5630 (−46.38%) |
Apr 20, 2026 27w ago | S-1 | $1.30 $1.05 | ▲ +19.23% | ▲ +26.13% | $0.5630 (+56.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers